<DOC>
	<DOCNO>NCT00268918</DOCNO>
	<brief_summary>The main purpose study see study drug , PTK787 , safe find high dose give safely without cause serious side effect .</brief_summary>
	<brief_title>Docetaxel PTK787 Metastatic Breast Cancer Patients Gynecological Cancer Patients</brief_title>
	<detailed_description>- Patients come clinic week receive study treatment . To help reduce chance allergic reaction patient take Decadron tablet orally night , morning evening receive chemotherapy . - The lead-in schedule dose follow : Day 1 : Taxotere intravenously ; Day 4 : PTK787 orally ; Day 14 : Taxotere PTK787 . - After lead-in schedule , cycle consist 28 day . PTK787 give orally day without interruption . Taxotere give Day 1 , Day 8 , Day 15 Day 22 . - Before dose Taxotere , blood test , urine test , physical exam do . A radiological evaluation do every two month . If patient tumor remain stable shrink size , may continue stay study . - Patients eat grapefruit drink grapefruit juice study .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Fallopian Tube Neoplasms</mesh_term>
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Vatalanib</mesh_term>
	<criteria>Recurrent gynecological cancer metastatic breast cancer . Initial diagnosis must confirm histologically . Measurable disease nonmeasurable disease Age &gt; 18 year ECOG performance 0,1,2 4 week great since major surgery , 3 week great since chemotherapy Certain lab value Negative proteinuria Four treatment regimens History presence uncontrolled CNS disease Prior biologic immunotherapy less 3 week prior registration Prior full field radiotherapy le 4 week limited field radiotherapy le 2 week prior registration Prior therapy antiVEGF agent Peripheral neuropathy functional impairment &gt; CTC grade 2 Pregnant breast feed Concurrent severe and/or uncontrolled medical condition Chronic renal disease Acute chronic liver disease Impairment gastrointestinal function GI disease Confirmed diagnosis HIV infection exclude investigator discretion Therapeutic warfarin sodium similar oral anticoagulant metabolize cytochrome p450 system .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>PTK787</keyword>
	<keyword>Metastatic breast cancer</keyword>
	<keyword>Refractory gynecological cancer</keyword>
</DOC>